Biliary Interventional Radiology Devices Market Analysis

  • Report ID: 3162
  • Published Date: Sep 23, 2024
  • Report Format: PDF, PPT

Biliary Interventional Radiology Devices Market Analysis

The biliary interventional radiology devices market is segmented based on product type into angiography systems, fluoroscopy systems, CT scanners, MRI systems, ultrasound-imaging systems, and others, out of which MRI systems hold the highest share in the market. Advancement in technologies and new product launches attribute the market growth.

On the basis of procedure, the biliary interventional radiology devices market is segmented into angiography, angioplasty, embolization, thrombolysis, vertebroplasty, nephrostomy, and others.  Angiography is projected to grow significantly over the forecast period. Due to, rising prevalence of cardiovascular diseases and the growing demand for minimally invasive procedures.

Based on application, the market is segmented into cardiology, oncology, urology & nephrology, gastroenterology, and others. Out of which, oncology holds the highest share in the market due to the rising prevalence of cancer, rising research initiatives, and growing geriatric population.

On the basis of end-user, the market is segmented into general medical & surgical hospitals, specialty hospitals, clinics, and others. Specialty hospitals hold the highest share in the market as a considerable portion of the population with chronic diseases on a global level tend to choose healthcare facilities specializing in its treatment.

Our in-depth analysis of the global market includes the following segments

By Product Type

  • Angiography Systems
  • Fluoroscopy Systems
  • CT scanners
  • MRI systems
  • Ultrasound-Imaging Systems
  • Others

 By Procedure Type

  • Angiography
  • Angioplasty
  •  Embolization
  •  Thrombolysis
  •  Vertebroplasty
  •  Nephrostomy
  •  Other

By Application

 

  • Fertility Clinics
  • Research Institutes
  • Others

By Application

 

  • Cardiology
  • Oncology
  • Urology & Nephrology
  • Gastroenterology
  • Other

 By End User

 

  • General Medical & Surgical Hospitals
  • Specialty Hospitals
  • Clinics
  • Others
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3162
  • Published Date: Sep 23, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Rising occurrence of cancer, chronic diseases and increasing elderly population are the key factors driving market growth.

The market is anticipated to attain a moderate CAGR over the forecast period, i.e., 2021-2029.

Costly therapies and lack of awareness about cancer therapies in lower economic regions are estimated to hamper market growth.

The market in Asia Pacific region will provide ample growth opportunities owing to the increasing awareness about cancer.

The major players dominating the are GE Healthcare (General Electric Company), Siemens Healthcare GmBH, Toshiba Medical Systems Corporation, Hitachi Medical Corporation, Carestream Health, Inc., Esaote S.p.A, Hologic, Inc., Fujifilm Corporation, Samsung Medison among others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample